The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cisplatin dose intensity (CDDP-D) in human papillomavirus-positive (HPV+) localized oropharyngeal carcinoma (OPC) treated with chemoradiotherapy (CRT).
 
Marc Oliva Bernal
No Relationships to Disclose
 
Shao Hui Huang
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Jie Su
No Relationships to Disclose
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Merck Serono; Pfizer
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Andrew J. Hope
Travel, Accommodations, Expenses - Elekta
 
Raymond Woo-Jun Jang
Consulting or Advisory Role - Ipsen
Research Funding - AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Andrew Bayley
No Relationships to Disclose
 
Eric Xueyu Chen
No Relationships to Disclose
 
Meredith Elana Giuliani
Travel, Accommodations, Expenses - Elekta
 
Jolie Ringash
No Relationships to Disclose
 
Scott Victor Bratman
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.
 
John Cho
No Relationships to Disclose
 
John Waldron
No Relationships to Disclose
 
Ilan Weinreb
No Relationships to Disclose
 
Douglas Brian Chepeha
No Relationships to Disclose
 
John Kim
No Relationships to Disclose
 
Brian O'Sullivan
Consulting or Advisory Role - IBA; Merck; Merck; Pfizer
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; MorphoSys; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)
 
Anna Spreafico
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb; Merck; Novartis